Compare SRZN & GFUZW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SRZN | GFUZW |
|---|---|---|
| Founded | 2015 | N/A |
| Country | United States | United States |
| Employees | 44 | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Electric Utilities: Central |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 271.6M | 318.2M |
| IPO Year | N/A | 2025 |
| Metric | SRZN | GFUZW |
|---|---|---|
| Price | $25.26 | $1.95 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $38.00 | N/A |
| AVG Volume (30 Days) | ★ 249.8K | 100.5K |
| Earning Date | 05-08-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $75.35 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.55 | $1.26 |
| 52 Week High | $35.00 | $2.30 |
| Indicator | SRZN | GFUZW |
|---|---|---|
| Relative Strength Index (RSI) | 47.35 | 61.50 |
| Support Level | $20.26 | $1.42 |
| Resistance Level | $24.13 | $2.23 |
| Average True Range (ATR) | 1.89 | 0.33 |
| MACD | 0.25 | 0.04 |
| Stochastic Oscillator | 66.67 | 69.23 |
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-8141(for wet AMD, DME), SZN-413( For retinopathies) and SZN-8143 (for wet AMD, DME, UME).